Abstract
Background
Transoral endoscopic thyroidectomy vestibular approach is expected to be a safe alternative to open surgery for certain patients and has been used increasingly by several surgeons around the world for the past 2 years. The purpose of this paper is to review our 2-year experience and describe in detail our preoperative considerations, patient selection, operating room settings, anesthetic considerations, surgical technique, postoperative management, and outcomes.
Methods
We reviewed the medical records of 65 consecutive patients who underwent transoral endoscopic thyroidectomy between July 2016 and May 2018 in our hospital.
Results
We have performed 65 thyroid surgeries (54 thyroid lobectomies, 1 completion thyroidectomy, and 10 total thyroidectomies) in 64 patients. Postoperative pathology revealed papillary carcinoma in 55 patients (84.6%), follicular carcinoma in two (3.1%), hyalinizing trabecular tumor in one (1.5%), and other benign tumor in seven (10.8%). All surgical margins were negative. Two (3.1%) patients developed transient vocal cord palsy but recovered within 2 months. One (1.5%) patient with vocal cord palsy had not recovered by 3 months after surgery. Five (7.7%) patients who underwent total thyroidectomy developed transient hypocalcemia but recovered within 2 months.
Conclusion
Although transoral thyroid surgery is a relatively recent technique requiring further validation, it affords several advantages. Transoral thyroid surgery has not yet been universally accepted, but may be the best choice for thyroid surgery in the future.
Similar content being viewed by others
Avoid common mistakes on your manuscript.
The incidence of thyroid cancer in South Korea increased 15-fold between 1993 and 2011, and is currently the most common cancer in females [1]. Most thyroid cancers grow slowly and are seldom life-threatening, but are frequent in the 2nd to 3rd decades of life in young females; a visible hypertrophic scar in the center of the neck after surgery may be disturbing and stressful. Several authors have sought to minimize scarring or to split scars (to aid dispersion), but neck scarring persists. Therefore, efforts have been made to move the incision to an area normally covered with clothing, such as the axilla, breast, or retroauricular region [2]. Approaches commonly used in South Korea include the transaxillary and bilateral axillo-breast (BABA) methods; recently, the retroauricular approach has become popular among head-and-neck surgeons [3,4,5,6,7,8,9,10].
Natural orifice transluminal endoscopic surgery (NOTES) is the latest surgical technique for inserting an endoscope through the mouth, anus, vagina, etc., and for performing surgery with mucosal incision only without skin incision [11]. Recently, a number of researchers have sought to apply NOTES to thyroid surgery and several trials sought to remove the thyroid gland through oral cavity. Transoral thyroid surgery has been performed via two principal routes: the sublingual and vestibular routes, of which the former was associated with more complications and tissue damage [12,13,14,15]. Recently, a Chinese group reported successful results in 81 cases using a sublingual route of endoscopic insertion, although two cases were changed to open thyroidectomy because of intraoperative CO2 embolisms [16]. The vestibular route became widely known after Anuwong reported successful results in their first 60 patients: the transoral endoscopic thyroidectomy vestibular approach (TOETVA) has become increasingly recognized as a feasible novel surgical procedure [17]. Several researchers from various countries have reported successful initial results after attempting TOETVA or a similar method [18,19,20,21,22,23,24,25].
TOETVA is expected to be a safe alternative to open surgery for certain patients and has been used increasingly by several surgeons around the world for the past 2 years. The purpose of this paper is to review our 2-year experience (all procedures were performed by the same surgeon); summarize the existing literature; and describe in detail our preoperative considerations, patient selection, operating room settings, anesthetic considerations, surgical technique, postoperative management, and outcomes.
Materials and methods
Indications and contraindications
We reviewed the medical records of 65 consecutive patients who underwent TOETVA between July 2016 and May 2018 in our hospital. All patients were operated on in the same manner, and by the same surgeon (JO Park). The patients were 53 females and 12 males of mean age 42.9 years (range: 19–66 years). Transoral completion surgery was performed after initial transoral thyroid lobectomy in one female. The inclusion criteria were (1) no prior surgical treatment or radiation to the head-and-neck and/or mediastinum (exceptionally, in one case, the permanent pathology revealed a follicular carcinoma after transoral thyroid lobectomy and completion transoral thyroid lobectomy was performed on the 9th postoperative day); (2) provision of consent (the transoral approach was explained to all patients and their families before operation, and written, informed patient consent obtained); (3) no extrathyroidal extension or lymph node metastasis evident on preoperative ultrasonography; and (4) a suspected or confirmed thyroid cancer < 2 cm in diameter on the mid/lower lobe or < 1 cm in diameter on the superior lobe; and (5) a benign tumor < 8 cm in diameter. Our Institutional Review Board approved the study.
Preoperative evaluation
Thorough history-taking included an exploration of why the patient is motivated to try the new surgical approach, any previous keloid issues, and any previous history of head-and-neck surgery, head-and-neck irradiation, or clinical hyperthyroidism. We check if any patient had a protruding chin or prominent Adam’s apple (which can cause certain issues during surgery). We also checked oral hygiene status, vocal cord paralysis status, and body fat composition. If an oral abscess or acute inflammation is evident near the lower vestibule, surgery is delayed because of a risk of wound infection. We obtained neck computed tomography (CT) scans to check the location and size of the anterior jugular vein, and if the course of the innominate artery is high. We also checked if the Zuckerkandl tubercle is prominent; this can render identification and preservation of the recurrent laryngeal nerve difficult (Fig. 1).
Setting, instruments, and operating room
A 10-mm-diameter, 30° rigid endoscope is usually used for transoral thyroid surgery. The usual endoscopic instruments included a Babcock forceps, a Johann forceps, a right-angled forceps, a short Maryland forceps, and an ultrasonic device. Three cannulas are used to position the instruments (two 5-mm-diameter cannulas for forceps and one 11-mm-diameter cannula for the endoscope). A Veress needle is used for hydro-dissection and blunt instruments (a vascular tunneller and a Kelly clamp) for creating and widening the working space. Excised specimens are routinely removed using an endoscopic pouch.
Patient positioning
The patient is usually administered general anesthesia via orotracheal intubation and an endotracheal tube is fixed to the right or left corner of the mouth (on the same side as the anesthesia equipment) to prevent it from falling out during surgery. The patient is usually placed in the supine position with a pillow under the back allowing the neck to be slightly extended. The patient’s head is fixed to the bed firmly using adhesive plaster so that the head does not turn during surgery (Fig. 2A). The oral cavity and anterior neck are disinfected employing the usual povidone/water solution. Draping is performed so that the upper lip is sufficiently exposed superiorly and the sternal notch inferiorly (Fig. 2B). The surgical team consists of four medical staff: an operator, the first assistant surgeon, the second assistant surgeon, and a scrub nurse (Fig. 2C). The operator usually sits or stands above the patient’s head. The operator sits on a chair with an armrest in a stable and comfortable posture. The first assistant surgeon stands on the right or left of the patient (opposite to the side of the lesion; thus on the right side if left thyroid lobectomy is planned) and secures the surgical view by holding the endoscope. The second assistant surgeon stands on the lesion side, and helps the surgeon to open and close the valve of the cannula, to pull the anchoring suture thread securing the working space, and with other procedures.
Creation of the working space
A 2-cm-sized curvilinear incision is made (via a Bovie cautery) in the midline of the vestibule about 1 cm distant from the gingiva and deepened to cut the medial portion of mentalis muscle which is attached to the mandible until the lower margin of the mandible is exposed (Fig. 3A, B). Once the mid-lower border of the mandible is exposed, a Veress needle is used to inject 40–50 mL of normal saline into the subplatysmal plane to hydro-dissect the working space (Fig. 3C). After completing hydro-dissection, the working space in the submental is cautiously widened, in a blind manner, using a blunt instrument such as a Kelly clamp (Fig. 3D). Then, a blunt-tip tissue dissector such as a vascular tunneller is inserted through the incision and advanced in a fan-shaped manner in the subplatysmal plane (Fig. 3E). The shape of the working space is that of a reverse triangle; the boundaries are the sternal notch inferiorly and the anterior borders of both sternocleidomastoid muscles laterally. A 11-mm-diameter cannula is inserted and CO2 gas insufflated at a pressure of 6 mmHg at a flow rate of 12–15 L/min. A 11-mm-diameter 30° telescope is inserted through the cannula to check that the working space is well-formed. Next, two lateral incisions are made in the vestibule near the second premolar or first molars, and a 5-mm-diameter cannula inserted through each incision (Fig. 3F, G). The mental nerve exits from the mental foramen of the mandible and runs anteriorly, and the mental foramen lies between the first and second premolars; therefore, it is safer to create the incision posteriorly [20]. Peng et al. recently reported a modified technique, creating a large 6-cm incision at the oral vestibule, identifying the bilateral mental nerves, and inserting a 10-mm trocar at the midpoint of the vestibule and two 5-mm trocars lateral or medial to the mental nerve [22]. A short Maryland forceps, L-hook cautery, and an ultrasonic device are positioned through each lateral cannula to widen the working space along the subplatysmal plane to the sternal notch inferiorly, and to both sternocleidomastoid muscles laterally.
Insufflation of carbon dioxide and monitoring of end-tidal carbon dioxide level
Generally, the initial CO2 pressure do not exceed 6 mmHg, and is held at 3–4 mmHg during surgery to maintain the working space; the flow rate is 12–15 L/min. We work closely with the anesthesiologist to continuously monitor the end-tidal CO2 level (ETCO2); we ensure that it does not exceed 40 mmHg if at all possible. If the ETCO2 exceeds 40 mmHg during surgery, we lower the gas pressure and continue surgery; if the ETCO2 remains above 40 mmHg, the operation is paused, gas flow stopped, and ventilation started.
Exposure of the thyroid gland and dissection of the upper pole
The median raphe of strap muscle is divided using L-hook cautery or ultrasonic device to expose the thyroid isthmus (Fig. 4A). The strap muscle is detached from the thyroid gland and a percutaneous suture is made using 2–0 black silk from the outside to penetrate the strap muscle before re-exiting via the skin. This procedure is used to retract the strap muscle laterally and expose the thyroid gland during surgery (thus similar to strap muscle retraction using the Army and Navy during open thyroid surgery) (Fig. 4B). Dissection progressed medially and the isthmectomy is completed using an ultrasonic device (Fig. 4C). We then move the device laterally to identify the avascular sternothyroid-laryngeal triangle, and hold and pull the superior pole medially using Babcock or Johann forceps to expose the superior thyroid vessels. Then, the superior thyroid artery and vein are divided using an ultrasonic device (Fig. 4D).
Preservation of the recurrent laryngeal nerve and parathyroid gland
After dividing the middle thyroid vein, the thyroid is retracted medially. With traction of thyroid gland medially, the trachea-esophageal groove and inferior thyroid artery are exposed. Under a magnified telescopic view, all important anatomical structures are identified and preserved including the parathyroid gland, the recurrent laryngeal nerve, and the carotid artery (Fig. 5). After anterior traction of the thyroid, Berry’s ligament is dissected from trachea and the unilateral lobe of the thyroid gland completely removed.
Removal of the specimen and closure
The specimen is removed using endoscopic pouches inserted through the midline incision site (Fig. 6). If the thyroid gland or the major nodule is large, or the mandible protrudes, it may be difficult to remove the specimen entirely through the midline incision site. In such cases, it is helpful to lengthen the incisions on both sides or to remove the pillow from under the patient’s back to place the neck in flexion. If a benign nodule is obvious preoperatively, the specimen can be removed after it is split into several pieces within the endoscopic pouch. Initially, we did not insert drains in patients who underwent lobectomy, but we experienced some cases of seroma. Currently, we insert negative suction drains through a lateral incision in the oral cavity. The strap muscles are re-approximated, and the three incision sites closed using absorbable sutures.
Postoperative care
A pressure dressing is placed around the chin and neck using an elastic bandage and removed 48 h later; the suction drain is routinely removed after a further 24 h. Following surgery, oxygen is supplied through a mask; we monitor oxygen saturation, dyspnea signs, and subcutaneous emphysema. A soft diet is given on the day of operation and a regular diet commences on postoperative day 1 or 2. Intravenous antibiotics are given during the hospital stay and oral antibiotics are prescribed after discharge. Currently, we are gradually reducing the duration of therapy and levels of antibiotics. Oral mucosal suture materials are removed on the first visit to the outpatient clinic.
Results
We have performed 65 thyroid surgeries (54 thyroid lobectomies, 1 completion thyroidectomy, and 10 total thyroidectomies) in 64 patients. The radiological findings, pathological features, operative details, and postoperative progress notes of all patients are summarized in Table 1. The postoperative complications are summarized in Table 2. Two patients developed transient vocal cord palsy but recovered within 2 months. One patient with vocal cord palsy had not recovered by 3 months after surgery, but the voice quality was quite good and we have scheduled 3 more months of follow-up. Five of ten patients (50%) who underwent total thyroidectomy developed transient hypocalcemia but recovered within 2 months. One patient with a 7.5-cm-diameter benign tumor developed transient lower lip sensory loss, but recovered within 1 month. Seven patients developed subcutaneous emphysema, but the symptoms were mild and recovery spontaneous. Four patients developed seroma, but recovered after aspiration. No patient developed a wound infection or fistula between the oral incision and anterior neck. No visible scar or dimpling was evident on the neck of any patient.
Discussion
Transoral endoscopic thyroid surgery has only recently become popular and no clear evidence-based indications or contraindications have yet been established. Recently, Razavi et al. [26] reviewed relevant articles in the English-language literature. Most authors agree that the most important indication for transoral thyroid surgery is the patient’s agreement, but no consensus on the maximum volume of the thyroid gland or major nodule to be removed has appeared. It has been recommended that the thyroid gland should be < 10 cm in diameter, and the major nodule < 6 cm, if a benign or indeterminate condition is suspected, but the major nodule should be < 2 cm if malignancy is suspected. However, we use slightly different indications. In our experience, if the major nodule is large, it is difficult to remove the specimen entirely through oral incision; the specimen must be cut into several pieces. Thus, it seems safer to consider other approaches when treating large indeterminate nodules (Bethesda classes III and IV) if undamaged specimens are required for accurate diagnosis. We perform transoral endoscopic thyroid surgery when benign tumors are 6–8 cm in diameter. However, if malignancy is either suspected or confirmed, the tumor diameter should be < 2 cm. In addition, if a suspect or confirmed malignant tumor is on the superior pole, the tumor diameter should be < 1 cm because the superior pole is poorly visible and a good deal of manipulation is required for visualization and ligation. The prime concern is tumor spillage during manipulation (Fig. 1C). In terms of benign tumors, we have removed nodules up to 8 cm in diameter. Anuwong et al. reported their experience with a 10-cm-diameter benign tumor and commented that 6–8 cm should be considered as the upper limit, especially for surgeons with limited experience [27]. Razavi et al. [26] recommended absolute contraindications as follows: previous head-and-neck surgery/irradiation (including of the mediastinum); an inability to tolerate general anesthesia; acute clinical hyperthyroidism; recurrent laryngeal nerve paralysis; a substernal thyroidal extension; preoperative evidence of lymph node metastasis or extrathyroidal extension; an oral abscess; and failure to meet the indications. Less absolute contraindications were Hashimoto’s thyroiditis and obesity. In terms of accessing the central node, it was recommended (in another paper) that this could be performed contemporaneously with transoral total thyroidectomy, either prophylactically if the surgeon routinely performs prophylactic central node dissection or therapeutically if paratracheal lymph node metastasis is newly found during operation [28].
When a beginner commences transoral surgery, it is most important to choose appropriate patients (i.e., those for whom safe and easy removal of the thyroid gland is possible). How might such patients be defined? In general, a right-handed surgeon finds it easier to remove nodules in the right thyroid lobe. Tumors located in the upper lobes of the thyroid may interfere with dissection of the superior pole and, if the tumor is large, it may obstruct the surgical view of the retrothyroidal area. Therefore, a small nodule located in the right middle or lower lobe is the best choice for right-handed beginners. Zuckerkandl’s tubercle development, obesity, mandibular development, and a prominent Adam’s apple constitute obstacles to transoral surgery. The surgeon may find it difficult to identify and preserve the recurrent laryngeal nerve in patients with prominent Zuckerkandl’s tubercles (Table 3).
Patel et al. [26] considered it difficult to check whether the tube is well-fixed by the anesthesiologist during surgery, because the surgeon is located at the patient’s head. Also, an oral tube consumes surgical field space and is prone to displacement during surgical manipulations. Anuwong et al. [27] routinely used nasotracheal intubation to deliver general anesthesia. Initially, we used the same approach, but now we employ routine orotracheal intubation; this has never caused any problems [20].
Carbon dioxide gas is injected to maintain the working space during surgery, possibly associated with gas-related complications. Fu et al. reported that 2 of 81 cases were transferred to open thyroidectomy because intraoperative CO2 embolisms developed [16]. Kim et al. reported one CO2 embolism developing during flap elevation prior to transoral robotic thyroidectomy; the patient was converted to a retroauricular approach [29]. Wilhelm et al. reported one case of mediastinal emphysema in eight patients (21%); this improved after conservative treatment [12]. Our previous paper describing 18 initial cases reported no gas-related complications [20]. However, we later experienced a case with a CO2 embolism developing after laceration of the anterior jugular vein during flap elevation, but the vital signs normalized within 1 min of vessel ligation and surgery continued. A low insufflation pressure is essential to prevent gas emboli [27]. We generally set the initial CO2 pressure to 6 mm Hg, but this is changed to 3–4 mmHg during surgery to maintain the working space. The flow rate is set to 12–15 L/min. Anuwong et al. considered that the flow rate should be set to 15 L/min and the CO2 pressure should not exceed 6 mmHg, but the flow rate could be increased temporally to 20 L/min to create a wider working space when removing a large goiter [30]. We engage closely with the anesthesiologist to monitor the ETCO2 at all times; the value is not to exceed 40 mmHg if possible. CO2 absorption during extraperitoneal insufflation is higher than during intraperitoneal insufflation [31]. ETCO2 monitoring affords sensitive and noninvasive diagnosis of gas embolisms, which may either raise or lower the ETCO2. Several reports have described increases in the ETCO2 values of patients with CO2 embolisms. The ETCO2 exhibits small transient increases after large CO2 boluses, probably attributable to increased blood gas levels. A rapid decrease in the ETCO2 is caused by obstruction of some of the pulmonary vasculature by emboli, expanding the ventilatory dead space [31].
We experienced one case of repeat transoral thyroidectomy performed 9 days after initial transoral thyroid lobectomy, because the pathologist diagnosed a follicular carcinoma. We encountered no problem during repeat surgery. Anuwong et al. [27] recommended that repeat transoral thyroid surgery on the contralateral thyroid gland be performed within 2 weeks or after 6 months of the first surgery.
Conclusions
Although transoral thyroid surgery is a relatively recent technique requiring further validation, it affords several advantages. The greatest advantage is that the operation can be performed via mucosal incision; no skin incision (which would need dressing and is associated with possible hypertrophic scarring and pigmentation) is required. Compared to other endoscopic approaches, the transoral route is the shortest route to the thyroid gland and as the endoscope is inserted centrally, the approach is optimal when total thyroidectomy is necessary. Transoral thyroid surgery has not yet been universally accepted, but may be the best choice for thyroid surgery in the future.
References
Ahn HS, Kim HJ, Welch HG (2014) Korea’s thyroid-cancer “epidemic"--screening and overdiagnosis. N Engl J Med 371:1765–1767
Tan CT, Cheah WK, Delbridge L (2008) “Scarless” (in the neck) endoscopic thyroidectomy (SET): an evidence-based review of published techniques. World J Surg 32:1349–1357
Kang SW, Jeong JJ, Nam KH, Chang HS, Chung WY, Park CS (2009) Robot-assisted endoscopic thyroidectomy for thyroid malignancies using a gasless transaxillary approach. J Am Coll Surg 209:e1–e7
Yoon JH, Park CH, Chung WY (2006) Gasless endoscopic thyroidectomy via an axillary approach: experience of 30 cases. Surg Laparosc Endosc Percutan Tech 16:226–231
Kang SW, Jeong JJ, Yun JS, Sung TY, Lee SC, Lee YS, Nam KH, Chang HS, Chung WY, Park CS (2009) Robot-assisted endoscopic surgery for thyroid cancer: experience with the first 100 patients. Surg Endosc 23:2399–2406
Kang SW, Lee SC, Lee SH, Lee KY, Jeong JJ, Lee YS, Nam KH, Chang HS, Chung WY, Park CS (2009) Robotic thyroid surgery using a gasless, transaxillary approach and the da Vinci S system: the operative outcomes of 338 consecutive patients. Surgery 146:1048–1055
Choe JH, Kim SW, Chung KW, Park KS, Han W, Noh DY, Oh SK, Youn YK (2007) Endoscopic thyroidectomy using a new bilateral axillo-breast approach. World J Surg 31:601–606
Terris DJ, Singer MC, Seybt MW (2011) Robotic facelift thyroidectomy: II. Clinical feasibility and safety. Laryngoscope 121:1636–1641
Terris DJ, Singer MC (2012) Qualitative and quantitative differences between 2 robotic thyroidectomy techniques. Otolaryngol Head Neck Surg 147:20–25
Byeon HK, Kim DH, Chang JW, Ban MJ, Park JH, Kim WS, Choi EC, Koh YW (2016) Comprehensive application of robotic retroauricular thyroidectomy: the evolution of robotic thyroidectomy. Laryngoscope 126:1952–1957
Moris DN, Bramis KJ, Mantonakis EI, Papalampros EL, Petrou AS, Papalampros AE (2012) Surgery via natural orifices in human beings: yesterday, today, tomorrow. Am J Surg 204:93–102
Wilhelm T, Metzig A (2011) Endoscopic minimally invasive thyroidectomy (eMIT): a prospective proof-of-concept study in humans. World J Surg 35:543–551
Wang Y, Xie QP, Yu X, Xiang C, Zhang ML, Zhao QZ, Yan HC, Wang P, Xu SM (2017) [Preliminary experience with transoral endoscopic thyroidectomy via vestibular approach: a report of 150 cases in a single center]. Zhonghua Wai Ke Za Zhi 55:587–591
Karakas E, Steinfeldt T, Gockel A, Westermann R, Kiefer A, Bartsch DK (2010) Transoral thyroid and parathyroid surgery. Surg Endosc 24:1261–1267
Nakajo A, Arima H, Hirata M, Mizoguchi T, Kijima Y, Mori S, Ishigami S, Ueno S, Yoshinaka H, Natsugoe S (2013) Trans-oral video-assisted neck surgery (TOVANS). A new transoral technique of endoscopic thyroidectomy with gasless premandible approach. Surg Endosc 27:1105–1110
Fu J, Luo Y, Chen Q, Lin F, Hong X, Kuang P, Yan W, Wu G, Zhang Y (2018) Transoral endoscopic thyroidectomy: review of 81 cases in a single institute. J Laparoendosc Adv Surg Tech A 28:286–291
Anuwong A (2016) Transoral endoscopic thyroidectomy vestibular approach: A series of the first 60 human cases. World J Surg 40:491–497
Chai YJ, Chung JK, Anuwong A, Dionigi G, Kim HY, Hwang KT, Heo SC, Yi KH, Lee KE (2017) Transoral endoscopic thyroidectomy for papillary thyroid microcarcinoma: initial experience of a single surgeon. Ann Surg Treat Res 93:70–75
Dionigi G, Bacuzzi A, Lavazza M, Inversini D, Boni L, Rausei S, Kim HY, Anuwong A (2017) Transoral endoscopic thyroidectomy: preliminary experience in Italy. Updates Surg 69:225–234
Park JO, Sun DI (2017) Transoral endoscopic thyroidectomy: our initial experience using a new endoscopic technique. Surg Endosc 31:5436–5443
Dionigi G, Tufano RP, Russell J, Kim HY, Piantanida E, Anuwong A (2017) Transoral thyroidectomy: advantages and limitations. J Endocrinol Invest 40:1259–1263
Peng XW, Li H, Li Z, Zhou X, Song DJ, Zhou B, Lv CL, Peng W (2017) Modified transoral endoscopic thyroid surgery for treatment of thyroid cancer: operative steps and video. Gland Surg 6:742–744
Kim HY, Chai YJ, Dionigi G, Anuwong A, Richmon JD (2018) Transoral robotic thyroidectomy: lessons learned from an initial consecutive series of 24 patients. Surg Endosc 32:688–694
Jitpratoom P, Ketwong K, Sasanakietkul T, Anuwong A (2016) Transoral endoscopic thyroidectomy vestibular approach (TOETVA) for Graves’ disease: a comparison of surgical results with open thyroidectomy. Gland Surg 5:546–552
Chai YJ, Kim HY, Kim HK, Jun SH, Dionigi G, Anuwong A, Richmon JD, Tufano RP (2018) Comparative analysis of 2 robotic thyroidectomy procedures: Transoral versus bilateral axillo-breast approach. Head Neck 40:886–892
Razavi CR, Russell JO (2017) Indications and contraindications to transoral thyroidectomy. Ann Thyroid 2:12
Anuwong A, Sasanakietkul T, Jitpratoom P, Ketwong K, Kim HY, Dionigi G, Richmon JD (2018) Transoral endoscopic thyroidectomy vestibular approach (TOETVA): indications, techniques and results. Surg Endosc 32:456–465
Razavi CR, Fondong A, Tufano RP, Russell JO (2017) Central neck dissection via the transoral approach. Ann Thyroid 2:11
Kim KN, Lee DW, Kim JY, Han KH, Tae K (2018) Carbon dioxide embolism during transoral robotic thyroidectomy: a case report. Head Neck 40:E25–E28
Anuwong A (2017) Strategy to prevent subcutaneous emphysema and gas insufflation-related complications in transoral endoscopic thyroidectomy vestibular approach: reply. World J Surg 41:2649–2650
Park EY, Kwon JY, Kim KJ (2012) Carbon dioxide embolism during laparoscopic surgery. Yonsei Med J 53:459–466
Acknowledgements
This work was supported by a National Research Foundation of Korea (NRF) grant funded by the Korea government (No. NRF-2014R1A2A2A03004802).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Disclosures
Dr. JO Park, Dr. A Anuwong, Dr. MR Kim, Dr. DI Sun, and Dr. MS Kim have no conflicts of interest or financial ties to disclose.
Rights and permissions
About this article
Cite this article
Park, JO., Anuwong, A., Kim, M.R. et al. Transoral endoscopic thyroid surgery in a Korean population. Surg Endosc 33, 2104–2113 (2019). https://doi.org/10.1007/s00464-018-6481-9
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00464-018-6481-9